phrykt

West Pharmaceutical Services (WST) revenue: $3.1B

West Pharmaceutical Services reported $3.1B of revenue for the year ended Dec 31, 2025, up 6.3% from $2.9B a year earlier.

From West Pharmaceutical Services's filings with the SEC · Read the filing · WST stock page

West Pharmaceutical Services revenue by year

$2.8B2021$2.9B2022$2.9B2023$2.9B2024$3.1B2025

#950 of 3,622 US companies by revenue · See the full ranking

Year endedRevenueChange
Dec 31, 2025$3.1B+6%
Dec 31, 2024$2.9B-2%
Dec 31, 2023$2.9B+2%
Dec 31, 2022$2.9B+2%
Dec 31, 2021$2.8B–

Revenue of similar companies

Companies in the same industry as West Pharmaceutical Services, by SEC industry code, with the closest revenue. Each name opens the same page for that company.

CompanyRevenue, latest yearYear ended
Dexcom$4.7BDec 31, 2025
MiniMed Group$3.1BApr 24, 2026
West Pharmaceutical Services$3.1BDec 31, 2025
Globus Medical$2.9BDec 31, 2025
Insulet$2.7BDec 31, 2025
Icu Medical$2.2BDec 31, 2025
Teleflex$2BDec 31, 2025

Questions and answers

What is West Pharmaceutical Services's revenue?

West Pharmaceutical Services reported $3.1B of revenue for the year ended Dec 31, 2025, up 6.3% from $2.9B a year earlier.

Numbers as reported in West Pharmaceutical Services's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology